INTRODUCTION: In Duchenne muscular dystrophy (DMD), fat replacement of muscle may be a useful endpoint in trials of therapy, although progression in different muscle groups is uneven. In this study we assessed the progression of fat replacement with T(1) -weighted imaging over 2 9-month periods. METHODS: Eight ambulant, corticosteroid-treated boys with DMD were imaged at 3 Tesla at 3 time-points (baseline and 9 and 18 months) with T(1) -weighted imaging to measure fat replacement. RESULTS: The greatest increase in fat content was measured in the biceps femoris long head, vastus lateralis, and rectus femoris, whereas the biceps femoris short head and gluteus maximus progressed more slowly. None of the lower leg muscles studied changed significantly. CONCLUSIONS: MRI can measure specific changes in fat replacement of muscle over time, demonstrating the variability in rates of natural progression between muscle groups and identifying those muscles suitable for use as biomarkers in clinical trials.
INTRODUCTION: In Duchenne muscular dystrophy (DMD), fat replacement of muscle may be a useful endpoint in trials of therapy, although progression in different muscle groups is uneven. In this study we assessed the progression of fat replacement with T(1) -weighted imaging over 2 9-month periods. METHODS: Eight ambulant, corticosteroid-treated boys with DMD were imaged at 3 Tesla at 3 time-points (baseline and 9 and 18 months) with T(1) -weighted imaging to measure fat replacement. RESULTS: The greatest increase in fat content was measured in the biceps femoris long head, vastus lateralis, and rectus femoris, whereas the biceps femoris short head and gluteus maximus progressed more slowly. None of the lower leg muscles studied changed significantly. CONCLUSIONS: MRI can measure specific changes in fat replacement of muscle over time, demonstrating the variability in rates of natural progression between muscle groups and identifying those muscles suitable for use as biomarkers in clinical trials.
Authors: Donovan J Lott; Sean C Forbes; Sunita Mathur; Sean A Germain; Claudia R Senesac; H Lee Sweeney; Glenn A Walter; Krista Vandenborne Journal: Neuromuscul Disord Date: 2014-04-13 Impact factor: 4.296
Authors: Pierre G Carlier; Benjamin Marty; Olivier Scheidegger; Paulo Loureiro de Sousa; Pierre-Yves Baudin; Eduard Snezhko; Dmitry Vlodavets Journal: J Neuromuscul Dis Date: 2016-03-03
Authors: Brittany Lee-McMullen; Stephen M Chrzanowski; Ravneet Vohra; Sean C Forbes; Krista Vandenborne; Arthur S Edison; Glenn A Walter Journal: NMR Biomed Date: 2019-03-08 Impact factor: 4.044
Authors: Benjamin Leporq; Arnaud Le Troter; Yann Le Fur; Emmanuelle Salort-Campana; Maxime Guye; Olivier Beuf; Shahram Attarian; David Bendahan Journal: MAGMA Date: 2017-03-22 Impact factor: 2.310
Authors: Ami Mankodi; Courtney A Bishop; Sungyoung Auh; Rexford D Newbould; Kenneth H Fischbeck; Robert L Janiczek Journal: Neuromuscul Disord Date: 2016-07-28 Impact factor: 4.296
Authors: Christopher J Moore; Melissa C Caughey; Diane O Meyer; Regina Emmett; Catherine Jacobs; Manisha Chopra; James F Howard; Caterina M Gallippi Journal: Ultrasound Med Biol Date: 2018-08-31 Impact factor: 2.998
Authors: Ishu Arpan; Rebecca J Willcocks; Sean C Forbes; Richard S Finkel; Donovan J Lott; William D Rooney; William T Triplett; Claudia R Senesac; Michael J Daniels; Barry J Byrne; Erika L Finanger; Barry S Russman; Dah-Jyuu Wang; Gihan I Tennekoon; Glenn A Walter; H L Sweeney; Krista Vandenborne Journal: Neurology Date: 2014-08-06 Impact factor: 9.910
Authors: Sean C Forbes; Harneet Arora; Rebecca J Willcocks; William T Triplett; William D Rooney; Alison M Barnard; Umar Alabasi; Dah-Jyuu Wang; Donovan J Lott; Claudia R Senesac; Ann T Harrington; Erika L Finanger; Gihan I Tennekoon; John Brandsema; Michael J Daniels; H Lee Sweeney; Glenn A Walter; Krista Vandenborne Journal: Radiology Date: 2020-04-14 Impact factor: 11.105